- $300.26m
- $908.66m
- $798.89m
- 33
- 95
- 78
- 78
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | 27.92% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.01 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.38 | ||
| EV to EBITDA | 5.26 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.82% | ||
| Return on Equity | -2.28% | ||
| Operating Margin | 8.38% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 877.35 | 1,062.41 | 631.67 | 734.67 | 798.89 | 830.68 | 888.64 | 8.17% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
GoHealth, Inc. is a medicare-focused digital health company that operates a health insurance marketplace. The Company primarily offers Medicare plans, including, Medicare Advantage, Medicare Supplement and prescription drug plans. Its technology platform leverages modern machine-learning algorithms powered by insurance behavioral data to reimagine the optimal process for helping consumers find the health plan for their specific needs. Its Medicare Advantage offerings include Special Needs Plans (SNPs). SNPs are special kinds of Medicare Advantage plans that have benefits covering special health care or financial needs. Its Marketplace technology features decision support tools and integrates with health plan partner enterprise systems, enabling agents to quickly select the right health insurance plan for each consumer based on their specific needs and enroll them in those plans. It offers Encompass Connect and Encompass Engage services to its health plan partners.
Directors
- Clinton Jones CCH (43)
- Brandon Cruz CCH
- James Sharman PRE (62)
- Vance Johnston CFO (52)
- Shane Cruz COO (41)
- Travis Matthiesen OTH (37)
- Brian Farley SEC (51)
- Rahm Emanuel IND (61)
- Joseph Flanagan IND (49)
- Helene Gayle IND (66)
- Jeremy Gelber IND (45)
- Anita Pramoda IND (46)
- Miriam Tawil IND (36)
- Alexander Timm IND (32)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 27th, 2020
- Public Since
- July 15th, 2020
- No. of Employees
- 2,261
- Sector
- Insurance
- Industry
- Financials
- Exchange
NASDAQ Capital Market- Shares in Issue
- 23,096,777
- Address
- 222 West Merchandise Mart Plaza, CHICAGO, 60654
- Web
- https://www.gohealth.com/
- Phone
- +1 3123868200
- Auditors
- Ernst & Young LLP
Upcoming Events for GOCO
Gohealth Inc Annual Shareholders Meeting
Q2 2025 Gohealth Inc Earnings Release
Similar to GOCO
Abacus Global Management
NASDAQ Capital Market
American Coastal Insurance
NASDAQ Capital Market
Cheche
NASDAQ Capital Market
Conifer Holdings
NASDAQ Capital Market
Health In Tech
NASDAQ Capital Market
FAQ
What is the GoHealth share price?
As of Today at 19:53 UTC, shares in GoHealth are trading at $13.00. This share price information is delayed by 15 minutes.
How has the GoHealth share price performed this year?
Shares in GoHealth last closed at $13.00 and the price had moved by +25.73% over the past 365 days. In terms of relative price strength the GoHealth share price has outperformed the S&P500 Index by +16.11% over the past year.
What are the analyst and broker recommendations for GoHealth?
The overall consensus recommendation for GoHealth is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the GoHealth dividend yield?
GoHealth does not currently pay a dividend.
Does GoHealth pay a dividend?
GoHealth does not currently pay a dividend.
When does GoHealth next pay dividends?
GoHealth does not currently pay a dividend.
How do I buy GoHealth shares?
To buy shares in GoHealth you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of GoHealth?
As of the previous close price of $13.00, shares in GoHealth had a market capitalisation of $300.26m.
Where are GoHealth shares listed?
Here are the trading details for GoHealth:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: GOCO
What kind of share is GoHealth?
Based on an overall assessment of its quality, value and momentum GoHealth is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a GoHealth share price forecast for 2025?
The analyst consensus target price for shares in GoHealth is $22.25. That is 71.15% above the last closing price of $13.00.
Analysts covering GoHealth currently have a consensus Earnings Per Share (EPS) forecast of -$3.07 for the next financial year.
Find out moreWhat is the trend in the GoHealth share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like GoHealth. Over the past six months, its share price has outperformed the S&P500 Index by +31.17%.
As of the last closing price of $13.00, shares in GoHealth were trading +8.7% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the GoHealth PE Ratio?
The GoHealth PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $13.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of GoHealth?
GoHealth's management team is headed by:
- Clinton Jones - CCH
- Brandon Cruz - CCH
- James Sharman - PRE
- Vance Johnston - CFO
- Shane Cruz - COO
- Travis Matthiesen - OTH
- Brian Farley - SEC
- Rahm Emanuel - IND
- Joseph Flanagan - IND
- Helene Gayle - IND
- Jeremy Gelber - IND
- Anita Pramoda - IND
- Miriam Tawil - IND
- Alexander Timm - IND